<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2026.1786217</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Omega-3 fatty acids and immunometabolism in health and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Nunes</surname> <given-names>Everson Araujo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<uri xlink:href="https://loop.frontiersin.org/people/109985"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yamazaki</surname> <given-names>Ricardo Key</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<uri xlink:href="https://loop.frontiersin.org/people/2916581"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>de Brito</surname> <given-names>Gleisson Alisson Pereira</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<uri xlink:href="https://loop.frontiersin.org/people/1440520"/>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Human Health Sciences, University of Guelph</institution>, <city>Guelph, ON</city>, <country country="ca">Canada</country></aff>
<aff id="aff2"><label>2</label><institution>Federal University of the Southern Frontier</institution>, <city>Chapec&#x000F3;</city>, <country country="br">Brazil</country></aff>
<aff id="aff3"><label>3</label><institution>Institute of Life and Nature Sciences, Federal University of Latin American Integration</institution>, <city>Foz do Igua&#x000E7;u</city>, <country country="br">Brazil</country></aff>
<author-notes>
<corresp id="c001"><label>&#x0002A;</label>Correspondence: Everson Araujo Nunes, <email xlink:href="mailto:everson.nunes@uoguelph.ca">everson.nunes@uoguelph.ca</email>; Ricardo Key Yamazaki, <email xlink:href="mailto:ricardo.yamazaki@uffs.edu.br">ricardo.yamazaki@uffs.edu.br</email>; Gleisson Alisson Pereira de Brito, <email xlink:href="mailto:gleisson.brito@unila.edu.br">gleisson.brito@unila.edu.br</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-16">
<day>16</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>13</volume>
<elocation-id>1786217</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2026 Nunes, Yamazaki and de Brito.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Nunes, Yamazaki and de Brito</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-16">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>ALA &#x003B1;-linolenic acid</kwd>
<kwd>DHA - 22:6n-3</kwd>
<kwd>EPA - 20:5n-3</kwd>
<kwd>fish oil</kwd>
<kwd>immune activation</kwd>
<kwd>lymphocytes</kwd>
<kwd>macrophages</kwd>
<kwd>metabolism</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="3"/>
<word-count count="1332"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutritional Immunology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes notes-type="frontiers-research-topic">
<p><bold>Editorial on the Research Topic</bold> <ext-link xlink:href="https://www.frontiersin.org/research-topics/68882/omega-fatty-acids-and-immunometabolism-in-health-and-disease" ext-link-type="uri">Omega-3 fatty acids and immunometabolism in health and disease</ext-link></p></notes>
</front>
<body>
<p>Immunometabolism has become a central framework for understanding how metabolic pathways intersect with immune function to influence health and disease. This field reflects increasing recognition that nutrients directly influence immune signaling, inflammatory responses, and metabolic regulation. Among dietary factors, omega-3 polyunsaturated fatty acids have attracted sustained interest because of their capacity to modulate lipid metabolism, immune cell function, and inflammatory resolution. Eicosapentaenoic acid, docosahexaenoic acid, and the plant-derived precursor alpha linolenic acid are now understood to influence these processes across tissues and physiological contexts.</p>
<p>The Research Topic <italic>Omega-3 Fatty Acids and Immunometabolism in Health and Disease</italic> integrates evidence from population studies, clinical observations, and experimental models to examine how omega-3 fatty acids contribute to immunometabolic regulation. Rather than focusing on isolated outcomes, the included articles collectively advance understanding of shared immunometabolic mechanisms and critical windows during which omega-3 availability appears particularly influential. Across diverse models, studies converge on the idea that omega-3 fatty acids support metabolic flexibility and immune balance in ways that depend heavily on timing, dietary context, and interactions among fatty acids (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig position="float" id="F1">
<label>Figure 1</label>
<caption><p>Conceptual framework integrating omega-3 fatty acids and immunometabolism across biological scales.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-13-1786217-g0001.tif">
<alt-text content-type="machine-generated">Conceptual diagram illustrating the role of omega-3 fatty acids in immunometabolism across biological scales. At the center, a hexagon labeled &#x0201C;Omega-3 Fatty Acids and Immunometabolism&#x0201D; contains EPA, DHA, and ALA. Surrounding the center are four interconnected thematic domains arranged clockwise: (1) Population and Public Health, including cardiometabolic risk, aging populations, and dietary omega-3 insufficiency; (2) Clinical and Inflammatory Contexts, including immune recovery, inflammatory resolution, and pediatric inflammatory conditions; (3) Tissue Metabolism and Fatty Acid Balance, including omega-6 to omega-3 ratio, lipid handling, and endocrine signaling, illustrated with liver, muscle, and adipose tissue icons; and (4) Early-Life and Developmental Programming, including gestation and lactation, metabolic programming, and nutritional resilience, illustrated with a maternal&#x02013;infant icon. Bidirectional arrows connect all domains to the central hub, indicating reciprocal interactions. A bottom panel highlights key knowledge gaps and future directions, including human mechanistic studies, specialized pro-resolving mediators, sex-specific responses, and interactions with physical activity and the microbiome. </alt-text>
</graphic>
</fig>
<p>At the population level, long-term epidemiological analysis demonstrates that inadequate omega-3 intake continues to contribute meaningfully to cardiometabolic disease burden, even in settings where age-standardized mortality has declined. This relationship is illustrated by recent work quantifying the ischemic heart disease burden attributable to insufficient omega-3 intake across multiple decades and demographic strata (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1590278">Luo</ext-link>). These findings reinforce the public health relevance of omega-3 consumption and underscore the importance of dietary strategies that account for demographic shifts such as population aging. Importantly, they also provide a necessary backdrop for interpreting mechanistic and interventional studies, linking cellular and tissue-level effects of omega-3 fatty acids to outcomes observed at the population scale.</p>
<p>Clinical relevance is further supported by emerging evidence that omega-3 fatty acids may contribute to immune recovery following severe inflammatory challenges. In pediatric populations recovering from multisystem inflammatory syndrome associated with SARS-CoV-2 infection, supplementation with docosahexaenoic acid has been associated with improvements in circulating omega-3 status and favorable trends in inflammatory markers (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1597868">Verduci et al.</ext-link>). Although exploratory, these observations suggest that omega-3 fatty acids may contribute to immune resolution during convalescence and highlight the potential for targeted nutritional approaches to complement existing clinical care.</p>
<p>A significant contribution of this Research Topic lies in its emphasis on early life as a sensitive period for immunometabolic programming. Experimental studies demonstrate that maternal omega-3 exposure during gestation and lactation can influence offspring metabolic trajectories, inflammatory signaling, and oxidative balance. In models of post-natal overfeeding, maternal fish oil supplementation attenuated metabolic and inflammatory disturbances in adult offspring (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1685437">Per&#x000ED;golo Lopes et al.</ext-link>), while complementary work using maternal supplementation with a plant-based omega-3 source showed protection against metabolic impairments induced by post-natal undernutrition (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1636396">Le&#x000E3;o et al.</ext-link>). Considered together, these studies indicate that omega-3 fatty acids contribute to metabolic resilience by shaping developmental trajectories, regardless of whether the early-life nutritional challenge involves excess or restriction.</p>
<p>Beyond absolute omega-3 intake, the studies in this Topic also advance understanding of the importance of dietary fatty acid balance and metabolic context. Experimental manipulation of the omega-6 to omega-3 ratio has demonstrated pronounced effects on lipid handling, endocrine signaling, and tissue-specific metabolic pathways. Evidence from controlled animal nutrition models indicates that reducing the dominance of omega-6 fatty acids improves growth efficiency, lipid profiles, and regulation of metabolic hormones. It modulates gene expression in the liver, intestine, and skeletal muscle (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fvets.2025.1643724">Guo et al.</ext-link>). Complementary mechanistic work further supports the role of omega-3 fatty acids in coordinating metabolic and inflammatory pathways across tissues, reinforcing the concept that omega-3 effects on immunometabolism extend beyond single organs or outcomes (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1614427">Liang et al.</ext-link>).</p>
<p>Taken together, the contributions in this Research Topic reinforce several key principles relevant to immunometabolism. Omega-3 fatty acids act across tissues and physiological systems to support coordinated metabolic and immune responses. Their effects are shaped not only by dose but also by the timing of exposure, interactions with other dietary fats, and the organism&#x00027;s metabolic state. Early developmental periods and recovery from inflammatory stress appear exceptionally responsive to omega-3 availability, suggesting that nutritional strategies should be context-specific rather than uniform across populations.</p>
<p>Despite these advances, significant gaps remain. The molecular pathways linking omega-3 fatty acids to immune resolution and metabolic adaptation require further clarification, particularly in human studies. The roles of specialized pro-resolving lipid mediators, tissue-specific signaling networks, and interactions with physical activity and the gut microbiome remain incompletely defined. In addition, future research must more effectively address sex-specific responses, interindividual variability, and the long-term sustainability of omega-3-rich dietary patterns in diverse populations. By integrating evidence across epidemiology, clinical research, developmental biology, and experimental nutrition, this Research Topic provides a cohesive view of omega-3 fatty acids as central regulators of immunometabolic health. Rather than presenting isolated findings, the Research Topic emphasizes convergent mechanisms and translational relevance, thereby positioning omega-3 fatty acids within a broader framework of metabolic and immune regulation. Continued interdisciplinary research will be essential to translate these insights into practical strategies for disease prevention and health promotion across the lifespan.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>EN: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing, Project administration, Conceptualization. RY: Conceptualization, Writing &#x02013; review &#x00026; editing, Project administration. GB: Writing &#x02013; review &#x00026; editing, Project administration, Conceptualization.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s2">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. Generative AI was used to make the figure summarizing the papers in the Research Topic.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited and reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/32064/overview">Willem Van Eden</ext-link>, Utrecht University, Netherlands</p>
</fn>
</fn-group>
</back>
 </article> 